Anthranilic Acid

Anthranilic Acid

SCHEMBL19019692

C[N+](C)(C)Cc1ccccc1.Nc1ccccc1C(=O)[O-]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.52
KDM4E B2RXH2 9/20 0.52
TDP1 Q9NUW8 2/20 0.52
HSD17B10 Q99714 7/20 0.44
HPGD P15428 7/20 0.44
TSHR P16473 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
TP53 P04637 1/20 0.44
GLA P06280 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
ALPL P05186 1/20 0.41
POLB P06746 1/20 0.41
ALPG P10696 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthranilic Acid SCHEMBL29420044 1.00 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1HSD17B10HPGD
Phthalic Acid SCHEMBL5875193 0.89 ALDH1A1 (0.61) ALDH1A1KDM4ETDP1HPGDTSHR
Anthranilic Acid SCHEMBL12490566 0.87 ALDH1A1 (0.55) ALDH1A1KDM4ETDP1HSD17B10HPGD
Phthalic Acid SCHEMBL8434834 0.84 ALDH1A1 (0.55) ALDH1A1KDM4ETDP1HPGDTSHR
Salicylic Acid SCHEMBL887131 0.83 KDM4E (0.59) ALDH1A1KDM4ETDP1HSD17B10HPGD
Bicarbonate SCHEMBL988119 0.81 ALDH1A1 (0.71) ALDH1A1KDM4ETDP1HSD17B10TSHR
Bicarbonate SCHEMBL988121 0.81 ALDH1A1 (0.71) ALDH1A1KDM4ETDP1HSD17B10TSHR
Bicarbonate SCHEMBL2774106 0.79 ALDH1A1 (0.68) ALDH1A1KDM4ETDP1HSD17B10TSHR
Oxalic Acid SCHEMBL153608 0.79 ALDH1A1 (0.68) ALDH1A1KDM4ETDP1HSD17B10TSHR
Acetic Acid SCHEMBL593316 0.79 ALDH1A1 (0.68) ALDH1A1KDM4ETDP1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001366-A1 IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS RICOH COMPANY, LTD. (JP) 2026-01-01 US disclosed
US-11235609-B2 Method for printing and printer RICOH COMPANY, LTD. (JP) 2022-02-01 US disclosed
US-20200391533-A1 METHOD FOR PRINTING AND PRINTER RICOH COMPANY, LTD. (JP) 2020-12-17 US disclosed
CN-110770308-A Ink, ink set, ink container, image forming method, and image forming apparatus 株式会社理光 2020-02-07 CN disclosed
US-9873252-B2 Printing device and printing method RICOH COMPANY, LTD. (JP) 2018-01-23 US disclosed
US-20170182770-A1 PRINTING DEVICE AND PRINTING METHOD RICOH COMPANY, LTD. (JP) 2017-06-29 US disclosed
EP-3184307-A1 PRINTING DEVICE AND PRINTING METHOD Ricoh Company, Ltd. (JP) 2017-06-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001366-A1 IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS IK, IPO7, PI4KA ALDH1A1 3299/4885KDM4E 3747/4885TDP1 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.